Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Analysis of CLSA Data - IA Brain Health

University of Ottawa

$69,743.00

Trajectories of Cognitive Function and Dementia Risk in Relation to Age at Menopause and Hormone Therapy Use

FY 2025-26

Summary
Women are at higher risk than men of developing Alzheimer's disease and related dementias. Hormonal changes that occur during menopause may partly explain this difference. Many women also report menopause-related "brain fog", but it is not clear how the age at menopause or the use of hormone therapy (HT) influence long-term cognition. This study will use data from the Canadian Longitudinal Study on Aging (CLSA), which has been following more than 50,000 Canadians since 2011, as well as provincial health records in Ontario. We will explore whether the age at which menopause occurs and the use of HT are linked to changes in cognition, self-reported memory concerns, and dementia diagnoses. We will also examine how other factors-such as mood, overall health, genetics, and biological aging-might interact with menopause timing and HT use to affect brain outcomes. We will address three key questions: 1. Does age at menopause or use of HT affect changes in cognitive function over time? 2. Are dementia diagnoses more or less common depending on age at menopause or HT use? 3. Are there lifestyle and biological factors that affect the risk of cognitive decline or dementia in women who experienced menopause early or who use HT? By following participants over up to 14 years, this project will provide new insights into how menopause and HT affect women's cognitive health across mid- and later life. The findings will help identify women who may be at greater risk of cognitive decline or dementia, and inform the development of sex-specific strategies to support healthy aging.
Program
Catalyst Grant: Analysis of CLSA Data - IA Brain Health
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
562825
Name
Taler Vanessa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Catalyst Grant: Analysis of CLSA Data
Projecttitle
Trajectories of Cognitive Function and Dementia Risk in Relation to Age at Menopause and Hormone Therapy Use
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$69,743
Cihrequipment2
$0
Programname2
Catalyst Grant: Analysis of CLSA Data - IA Brain Health
Keyworddelim
Cognition; Dementia; Hormone Therapy; Menopause
Abstract
Women are at higher risk than men of developing Alzheimer's disease and related dementias. Hormonal changes that occur during menopause may partly explain this difference. Many women also report menopause-related "brain fog", but it is not clear how the age at menopause or the use of hormone therapy (HT) influence long-term cognition. This study will use data from the Canadian Longitudinal Study on Aging (CLSA), which has been following more than 50,000 Canadians since 2011, as well as provincial health records in Ontario. We will explore whether the age at which menopause occurs and the use of HT are linked to changes in cognition, self-reported memory concerns, and dementia diagnoses. We will also examine how other factors-such as mood, overall health, genetics, and biological aging-might interact with menopause timing and HT use to affect brain outcomes. We will address three key questions: 1. Does age at menopause or use of HT affect changes in cognitive function over time? 2. Are dementia diagnoses more or less common depending on age at menopause or HT use? 3. Are there lifestyle and biological factors that affect the risk of cognitive decline or dementia in women who experienced menopause early or who use HT? By following participants over up to 14 years, this project will provide new insights into how menopause and HT affect women's cognitive health across mid- and later life. The findings will help identify women who may be at greater risk of cognitive decline or dementia, and inform the development of sex-specific strategies to support healthy aging.
Competitiondate
202510
Approvedterm2
1 yr 0 mth
Pinamesdelim
Taler, Vanessa
Approvedterm
1 an 0 mois
Cihrcontribution2
IA~ $69,743~ $0~